Teva gains on earnings beat
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Teva Pharmaceutical earnings per share 2006-2022 | Statista
Teva Pharmaceuticals on LinkedIn: #quarterlyresults #earnings #tevapharm
Teva Pharmaceutical Stock Dives Despite a Better-Than-Expected Earnings Report | Barron's
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
TEVA Stock | Teva Pharmaceutical Industries Ltd Q3 2021 Earnings Call - YouTube
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Teva Reports Third Quarter 2022 Financial Results
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva earnings Q2 2019 | AlphaStreet
Teva Pharmaceutical revenue 2006-2022 | Statista
Teva Stock Rallies After Q1 Earnings, Q2 Guidance Reassure Market | Investor's Business Daily
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva Pharmaceuticals on Twitter: "Teva just announced its Q2 2022 financial results. View the press release here: https://t.co/OGECc00hWU Forward-looking statements are subject to the cautionary note included in our Q2 2022 press
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking Alpha
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva rises on mixed-bag Q4, sets 2022 guidance - Drug Delivery Business
Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares - TheStreet
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited 2021 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
